nach oben

Quality of Life Research

Erschienen in:

01.02.2008

Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors

verfasst von: Yu-Tao Xiang, Yong-Zhen Weng, Chi-Ming Leung, Wai-Kwong Tang, Gabor S. Ungvari

Erschienen in: Quality of Life Research | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study compared the subjective quality of life (SQOL) in schizophrenia patients living with their families in Hong Kong (HK) and Beijing (BJ) and explored the relationship between SQOL and basic socio-demographic and clinical factors.

Materials and methods

Two hundred and sixty-four clinically stable outpatients with schizophrenia were randomly selected in HK and 258 counterparts matched according to age, sex, age at onset, and length of illness in BJ. SQOL and psychiatric status were assessed with standard rating instruments.

Results

There was no significant difference in any of SQOL domains between the two cohorts after controlling for potentially confounding variables. Positive, depressive and anxiety symptoms and drug-induced extrapyramidal side effects (EPS) were all significantly correlated with SQOL. Multiple regression analysis revealed that only depressive symptoms predicted all SQOL domains in both groups. Having removed depressive symptoms from the model, positive symptoms predicted all domains, anxiety predicted all but social domains, use of benzodiazepines (BZD) predicted all but physical domains, EPS predicted physical domain, and history of suicide predicted social domain in HK; anxiety predicted all domains, positive symptoms predicted all but physical domains, EPS, use of BZD and history of suicide all predicted physical domains, and length of illness predicted environmental domain in BJ.

Conclusion

Despite considerable differences between the two sites in terms of health care delivery and the economic conditions of the subjects, SQOL did not differ between HK and BJ. The conclusion is in line with previous studies that suggested that patients’ SQOL was independent of their living standard as long as it reached a certain minimum level. SQOL was more strongly related to the severity of depressive symptoms and had weak association with socio-demographic factors.

Xiang, Y., Weng, Y., Li, W., Gao, L., Chen, G., Xie, L., Chang, Y., Tang, W. K., & Ungvari, G. S. (2006). Training patients with schizophrenia with the community re-entry module: A controlled study. Social Psychiatry and Psychiatric Epidemiology, 41, 464–469.PubMedCrossRef

Chen, C. H., Shen, Y. C., Zhang, W. X., Li, S. R., Huang, Y. Q., Wang, J. R., & Wang, D. P. (1998). Epidemiological survey on schizophrenia in seven areas of China (in Chinese). The Chinese Journal of Psychiatry, 31, 72–74.

Weng, Y. Z., Xu, M. J., Li, D. L, Guo, F. Y., Huang, Q., & Fu, T. (2001). Assessment of expressed emotion in family members of schizophrenic patients in Beijing. Modern Rehabilitation, 5, 39–42.

Phillips, M. R., & Pearson, V. (1994). Future opportunities and challenges for the development of psychiatric rehabilitation in China. The British Journal of Psychiatry, 165(Suppl), 128–142.

Sartorius, N. (1997). Quality of life and mental disorders: A global perspective. Chichester: John Wiley.

Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., Larkin, C., & Callaghan, E. O. (1996). Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica, 94, 118–124.PubMedCrossRef

Law, C. W., Chen, E. Y., Cheung, E. F., Chan, R. C., Wong, J. G., Lam, C. L., Leung, K. F., & Lo, M. S. (2005). Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Quality of Life Research, 14, 1803–1811.PubMedCrossRef

Bechdolf, A., Klosterkotter, J., Hambrecht, M., Knost, B., Kuntermann, C., Schiller, S., & Pukrop, R. (2003). Determinants of subjective quality of life in post acute patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 253, 228–235.PubMedCrossRef

Ponizovsky, A. M., Grinshpoon, A., Levav, I., & Ritsner, M. S. (2003). Life satisfaction and suicidal attempts among persons with schizophrenia. Comprehensive Psychiatry, 44, 442–447.PubMedCrossRef

10.

Warner, R., de Girolamo, G., Belelli, G., Bologna, C., Fioritti, A., & Rosini, G. (1998). The quality of life of people with schizophrenia in Boulder, Colorado, and Bologna, Italy. Schizophrenia Bulletin, 24, 559–568.PubMed

11.

Heinze, M., Taylor, R. E., Priebe, S., & Thornicroft, G. (1997). The quality of life of patients with paranoid schizophrenia in London and Berlin. Social Psychiatry and Psychiatric Epidemiology, 32, 292–297.PubMedCrossRef

12.

Chan, G. W., Ungvari, G. S., Shek, D. T., & Leung Dagger, J. J. (2003). Hospital and community-based care for patients with chronic schizophrenia in Hong Kong—quality of life and its correlates. Social Psychiatry and Psychiatric Epidemiology, 38, 196–203.PubMedCrossRef

13.

Tan, H. Y., Choo, W. C., Doshi, S., Lim, L. E., & Kua, E. H. (2004). A community study of the health-related quality of life of schizophrenia and general practice outpatients in Singapore. Social Psychiatry and Psychiatric Epidemiology, 39, 106–112.PubMedCrossRef

14.

Lobana, A., Mattoo, S. K., Basu, D., & Gupta, N. (2001). Quality of life in schizophrenia in India: Comparison of three approaches. Acta Psychiatrica Scandinavica, 104, 51–55.PubMedCrossRef

15.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Erlbaum Hillsdale.

16.

Fang, J. Q., Hao, Y. T., & Li, C. X. (1999). Reliability and validity for Chinese version of WHO quality of life scale (in Chinese). Chinese Mental Health Journal, 13, 203–205.

17.

WHO (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science & Medicine, 41, 1403–1409.CrossRef

18.

Overall, J. E., & Beller, S. A. (1984). The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. Journal of Gerontology, 39, 187–193.PubMed

19.

Simpson, G. M., & Angus, J. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 212, 11–19.PubMedCrossRef

20.

Barnes, T. R. (1989). A rating scale for drug-induced akathisia. The British Journal of Psychiatry, 154, 672–676.PubMed

21.

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62.PubMed

22.

Wegener, S., Redoblado-Hodge, M. A., Lucas, S., Fitzgerald, D., Harris, A., & Brennan, J. (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. The Australian and New Zealand Journal of Psychiatry, 39, 487–492.PubMedCrossRef

23.

Corrigan, P. W., & Buican, B. (1995). The construct validity of subjective quality of life for the severely mentally ill. The Journal of Nervous and Mental Disease, 183, 281–285.PubMedCrossRef

24.

Hofer, A., Kemmler, G., Eder, U., Edlinger, M., Hummer, M., & Fleischhacker, W. W. (2004). Quality of life in schizophrenia: The impact of psychopathology, attitude toward medication, and side effects. The Journal of Clinical Psychiatry, 65, 932–939.PubMedCrossRef

25.

Hansson, L., Middelboe, T., Sorgaard, K. W., Bengtsson-Tops, A., Bjarnason, O., Merinderv, L., Nilsson, L., Sandlund, M., Korkeila, J., & Vinding, H. R. (2002). Living situation, subjective quality of life and social network among individuals with schizophrenia living in community settings. Acta Psychiatrica Scandinavica, 106, 343–350.PubMedCrossRef

26.

Patterson, T. L., Shaw, W., Semple, S. J., Moscona, S., Harris, M. J., Kaplan, R. M., Grant, I., & Jeste, D. V. (1997). Health-related quality of life in older patients with schizophrenia and other psychoses: Relationships among psychosocial and psychiatric factors. International Journal of Geriatric Psychiatry, 12, 452–461.PubMedCrossRef

27.

Eronen, M. (1995). Mental disorders and homicidal behavior in female subjects. The American Journal of Psychiatry, 152, 1216–1218.PubMed

28.

Yuen, C. H. (2004). Guideline on PFU system. In Doctors’ handbook. Hong Kong: Castle Peak Hospital.

29.

Luo, K., & Yu, D. (1994). Enterprise-based sheltered workshops in Nanjing. A new model for the community rehabilitation of mentally ill workers. The British Journal of Psychiatry Supplement, 165, 89–95.

30.

Phillips, M. R., Lu, S. H., & Wang, R. W. (1997). Economic reforms and the acute inpatient care of patients with schizophrenia: The Chinese experience. The American Journal of Psychiatry, 154, 1228–1234.PubMed

31.

Ng, C. (2007). Role of international collaboration in facilitating mental halth system change. In WPA Regional Conference/CSP Annual Congress. Shanghai, China, September 20–23, pp. 162–163.

32.

Sim, K., Su, A., Fujii, S., Yang, S. Y., Chong, M. Y., Ungvari, G. S., Si, T., Chung, E. K., Tsang, H. Y., Chan, Y. H., Heckers, S., Shinfuku, N., & Tan, C. H. (2004). Antipsychotic polypharmacy in patients with schizophrenia: A multicentre comparative study in East Asia. British Journal of Clinical Pharmacology, 58, 178–183.PubMedCrossRef

33.

Skantze, K., Malm, U., Dencker, S. J., May, P. R., & Corriganv, P. (1992). Comparison of quality of life with standard of living in schizophrenic out-patients. The British Journal of Psychiatry, 161, 797–801.PubMedCrossRef

34.

Fitzgerald, P. B., Williams, C. L., Corteling, N., Filia, S. L., Brewer, K., Adams, A., de Castella, A. R., Rolfe, T., Davey, P., & Kulkarni, J. (2001). Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica, 103, 387–392.PubMedCrossRef

35.

Larsen, E. B., & Gerlach, J. (1996). Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics. Acta Psychiatrica Scandinavica, 93, 381–388.PubMedCrossRef

36.

Lehman, A. F. (1988). A quality of life interview for the chronically mentally ill. Evaluation and Program Planning, 11, 51–62.CrossRef

37.

Huppert, J. D., & Smith, T. E. (2001). Longitudinal analysis of subjective quality of life in schizophrenia: Anxiety as the best symptom predictor. The Journal of Nervous and Mental Disease, 189, 669–675.PubMedCrossRef

38.

Awad, A. G. (1992). Quality of life of schizophrenic patients on medications and implications for new drug trials. Hospital & Community Psychiatry, 43, 262–265.

39.

Micallef, J., Fakra, E., & Blin, O. (2006). Use of antidepressant drugs in schizophrenic patients with depression. Encephale, 32, 263–269.PubMedCrossRef

40.

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J., & Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine, 353, 1209–1223.PubMedCrossRef

41.

Jones, P. B., Barnes, T. R., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006). Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of General Psychiatry, 63, 1079–1087.PubMedCrossRef

Titel: Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors
verfasst von: Yu-Tao Xiang
Yong-Zhen Weng
Chi-Ming Leung
Wai-Kwong Tang
Gabor S. Ungvari
Publikationsdatum: 01.02.2008
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 1/2008
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-007-9285-2

Springer Medizin

Abstract

Purpose

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Four weeks of daily assessments of anxiety, depression and activity compared to a point assessment with the Hospital Anxiety and Depression Scale

Reliability and validity of the social integration survey (SIS) in patients with schizophrenia

Analyzing growth and change: latent variable growth curve modeling with an application to clinical trials

The PedsQL™ Multidimensional Fatigue Scale in young adults: feasibility, reliability and validity in a University student population

Changes in health-related quality of life in patients of self-care vs. in-center dialysis during the first year

Comparison of anchor-based and distributional approaches in estimating important difference in common cold